Basic Information
ID: ALA4222932
Type: Toxicity
Description: Therapeutic index, ratio of TD50 for HFF to IC50 for tachyzoite stage of Toxoplasma gondii expressing beta-gal infected in HFF
Activity Charts
Bioactivity
Activity Types for Assay ALA4222932
TI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 282.34 | 2.39 | 2.39 |
| 240.24 | 3.14 | 3.14 |
| 252.27 | 3.01 | 3.01 |
| 252.27 | 3.01 | 3.01 |
| 349.48 | 4.71 | 4.71 |
| 355.44 | 4.18 | 4.18 |
| 366.84 | 5.51 | 5.51 |
| 265.32 | 3.07 | 3.07 |
| 223.24 | 2.40 | 2.40 |
| 301.14 | 3.35 | 3.35 |
| 328.37 | 4.17 | 4.17 |
| 266.26 | 2.32 | 2.32 |
| 407.27 | 4.82 | 4.82 |
| 483.37 | 6.39 | 6.39 |
| 412.53 | 6.22 | 6.22 |
| 456.14 | 5.58 | 5.58 |
| 434.50 | 5.64 | 5.64 |
| 410.52 | 6.15 | 6.15 |
| 468.64 | 7.78 | 7.78 |
| 306.24 | 3.49 | 3.49 |
| 464.61 | 7.34 | 7.34 |
| 407.27 | 4.82 | 4.82 |
| 385.30 | 5.41 | 5.41 |
| 372.38 | 3.79 | 3.79 |
| 336.44 | 4.65 | 4.65 |
| 347.46 | 4.63 | 4.63 |
| 471.56 | 6.37 | 6.37 |
| 448.52 | 5.59 | 5.59 |
| 405.59 | 6.27 | 6.27 |
| 418.50 | 5.69 | 5.69 |
| 385.47 | 4.08 | 4.08 |
| 398.51 | 5.69 | 5.69 |
| 335.45 | 4.18 | 4.18 |